BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3916499)

  • 1. Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection.
    Rabin BS; Griffith BP; Hardesty RL
    J Heart Transplant; 1985 May; 4(3):293-5. PubMed ID: 3916499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
    Hubscher SG; Adams DH; Elias E
    J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute vascular rejection involving the major coronary arteries of a cardiac allograft.
    Yowell RL; Hammond EH; Bristow MR; Watson FS; Renlund DG; O'Connell JB
    J Heart Transplant; 1988; 7(3):191-7. PubMed ID: 3290402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Imbalance among circulating T cell subsets and staining for HLA-DR antigen in coronary endothelial cells in Kawasaki disease].
    Terai M; Kohno Y; Niwa K; Umemiya T; Mikata A; Nakajima H
    Arerugi; 1987 Jul; 36(7):394-403. PubMed ID: 3500695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
    Arbustini E; Grasso M; Diegoli M; Gavazzi A; Campana C; Martinelli L; Goggi C; Pucci A; Grossi P; Ippoliti G
    G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR antigen expression on tubular and endothelial cells from fine-needle aspiration cytology.
    Carrera M; Combalia N; Griñó JM; Castelao AM
    Transplant Proc; 1988 Aug; 20(4):610-1. PubMed ID: 3043815
    [No Abstract]   [Full Text] [Related]  

  • 8. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
    Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
    Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.
    Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC
    J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
    Young E; Stark WJ; Prendergast RA
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of ICAM-1 and HLA-DR expression on renal allograft aspirates.
    Manfro RC; Goncalves LF; Rauber M; Moura LA
    Clin Transplant; 1996 Aug; 10(4):379-83. PubMed ID: 8884112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients.
    Milne DS; Gascoigne AD; Wilkes J; Sviland L; Ashcroft T; Malcolm AJ; Corris PA
    Transplantation; 1994 Jun; 57(12):1762-6. PubMed ID: 7912458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescence of endomyocardial biopsy specimens: methods and interpretation.
    Hammond EH; Hansen JK; Spencer LS; Jensen A; Yowell RL
    J Heart Lung Transplant; 1993; 12(2):S113-24. PubMed ID: 8476881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
    Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
    J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
    Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
    Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
    Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC antigen expression in sequential biopsies from cardiac transplant patients--correlation with rejection.
    Suitters A; Rose M; Higgins A; Yacoub MH
    Clin Exp Immunol; 1987 Sep; 69(3):575-83. PubMed ID: 3311497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
    De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
    Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.